维普中文期刊产品整合服务
15篇 您的检索式:作者名="Angèle"
    题名 作者 年代 出处 被引量
1Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans显示文摘Enrico Brunetti Peter Kern Dominique Angèle Vuitton 2009Acta Tropica2009,,1:2
2From Farming to Engineering: The Microbiota and Allergic Diseases显示文摘第二次世界大战之后,IgE依赖性过敏性疾病的发生呈稳步上升趋势,在人类发展史上,这种现象是很罕见的。许多大规模横断面研究、纵向队列研究及基础实验性研究均指出,在生活方式及生活环境的重大演变过程中人类的一些与过敏相关的'保护性因素'正逐渐消失。其中被广泛认可的观念是:肠道微生态在免疫调节方面扮演着重要角色。本文综述了暴露在不同微生物组成的农场环境对过敏性疾病的保护作用。此外,传统生活环境中的微生物如何促进儿童免疫系统的正常发育,以及此种相互作用在现代生活方式下的不可逆性缺失同样被阐明。'农场效应'的保护作用主要包括:母亲怀孕期间或婴儿期接触动物、谷仓、马厩,饮用未加工的牛奶和其他奶制品。除农场环境中的微生物总量之外,微生物的生物多样性似乎对于这种保护也至关重要,这可能归因于农场环境对机体肠道菌群生物多样性的贡献。过敏性疾病专科医生和儿科医生临床应用传统益生菌(如乳杆菌和双岐杆菌)对过敏性疾病的预防作用并未达到满意的预期效果。小鼠呼吸道过敏性疾病模型研究表明,牛棚中存在着对过敏性疾病起重要预防作用的微生物,如鲁氏不动杆菌(A.lwoffii)F78、乳酸乳球菌(L.lactis)G121和松鼠葡萄球菌(S.sciuri)W620。然而,在对农场环境的卓有成效的研究基础上,研发新一代益生菌仍需要微生物学家、免疫学家和生物工程师以及儿科医生、过敏性疾病专科医生、临床试验专家和伦理委员会之间的密切合作。Dominique Angèle Vuitton Jean-Charles Dalphin 2017Engineering2017,3,1:0
3Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans显示文摘Enrico Brunetti Peter Kern Dominique Angèle Vuitton 2009Acta Tropica2009,,1:4
4Characterization of root-nodulating bacteria on Retama raetam in arid Tunisian soils显示文摘The aim of this study is to investigate the diversity of Retama raetam root-nodule bacteria isolated from arid regions of Tunisia. Twelve isolates, chosen as representative for difierent 16S rRNA gene patterns, were characterized by 16S rRNA gene sequencing and phenotypic analysis. Isolates were assigned to Sinorhizobium, Rhizobium and Agrobacterium. Symbiotic properties of Sinorhizobium and Rhizobium isolates showed a large diversity in their capacity to infect their host plant and fix atmospheric nitrogen. Strain RK 22 identified as Rhizobium was the most effective isolate.Mosbah Mahdhi Angèle Nzoué Philippe de Lajudie Mohamed Mars 2008Progress in Natural Science:Materials International2008,18,1:1
5Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans显示文摘Enrico Brunetti Peter Kern Dominique Angèle Vuitton 2009Acta Tropica2009,,1:1
6Echinococcus multilocularis and Its Intermediate Host: A Model of Parasite-Host Interplay显示文摘Dominique Angèle Vuitton Bruno Gottstein Jorge Morales-Montor 2010Journal of Biomedicine and Biotechnology2010,,:1
7Diffusion of Solar Energy Use in the Built Environment Supported by New Design显示文摘Marina van Geenhuizen Joop Schoonman Angèle Reinders 2014Journal of Civil Engineering and Architecture2014,8,2:0
8Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: A prospective study显示文摘Marie Angèle Robic Bogdan Procopet Sophie Métivier Jean Marie Péron Janick Selves Jean Pierre Vinel Christophe Bureau 2011Journal of Hepatology2011,,5:1
9Secondary Ovarian Malignancies: Frequency, Origin, and Characteristics显示文摘Yvonne R. P. de Waal Chris M. G. Thomas Angèle L. M. Oei Fred C. G. J. Sweep Leon F. A. G. Massuger 2009International Journal of Gynecological Cancer2009,,7:1
10Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients显示文摘AIM: To determine the composition of both fecal and duodenal mucosa-associated microbiota in irritable bowel syndrome (IBS) patients and healthy subjects using molecular-based techniques. METHODS: Fecal and duodenal mucosa brush samples were obtained from 41 IBS patients and 26 healthy subjects. Fecal samples were analyzed for the composition of the total microbiota using fluorescent in situ hybridization (FISH) and both fecal and duodenal brush samples were analyzed for the composition of bif idobacteria using real-time polymerase chain reaction. RESULTS: The FISH analysis of fecal samples revealed a 2-fold decrease in the level of bifidobacteria (4.2 ± 1.3 vs 8.3 ± 1.9, P < 0.01) in IBS patients compared to healthy subjects, whereas no major differences in other bacterial groups were observed. At the species level, Bifidobacterium catenulatum levels were significantly lower (6 ± 0.6 vs 19 ± 2.5, P < 0.001) in the IBS patients in both fecal and duodenal brush samples than in healthy subjects.CONCLUSION: Decreased bifidobacteria levels in both fecal and duodenal brush samples of IBS patients compared to healthy subjects indicate a role for microbiotic composition in IBS pathophysiology.Angèle PM Kerckhoffs Melvin Samsom Michel E van der Rest Joris de Vogel Jan Knol Kaouther Ben-Amor Louis MA Akkermans 2009World Journal of Gastroenterology2009,15,23:33
11Imaging aspects and non-surgical interventional treatment in human alveolar echinococcosis显示文摘Solange Bresson-Hadni Eric Delabrousse Oleg Blagosklonov Brigitte Bartholomot Stéphane Koch Jean-Philippe Miguet Georges André Mantion Dominique Angèle Vuitton 2005Parasitology International2005,,:1
12Tolerance of liver biopsy in a tertiary care center: comparison of the percutaneous and the transvenous route in 143 prospectively followed patients显示文摘Bogdan Procopet Christophe Bureau Sophie Métivier Janick Selves Marie Angèle Robic Camille Christol Mircea Grigorescu Jean-Pierre Vinel Jean-Marie Péron 2012European Journal of Gastroenterology & Hepatology2012,,10:1
13Tolerance of liver biopsy in a tertiary care center: comparison of the percutaneous and the transvenous route in 143 prospectively followed patients显示文摘Bogdan Procopet Christophe Bureau Sophie Métivier Janick Selves Marie Angèle Robic Camille Christol Mircea Grigorescu Jean-Pierre Vinel Jean-Marie Péron 2012European Journal of Gastroenterology & Hepatology2012,,10:1
14Antioxidant activity of dichloromethane fraction of Dichrocephala integrifolia in Salmonella typhi-infected rats显示文摘Objective: Infectious diseases such as typhoid fever lead to the formation of free radicals which can damage the body. Many medicinal plants have antioxidant molecules that neutralize free radicals. The present work evaluated the antioxidant activity and histopathological effects of the dichloromethane fraction of Dichrocephala integrifolia in Salmonella typhi-infected rats.Methods: The S. typhi-infected rats concurrently received daily doses of D. integrifolia extract at doses of 25, 50 and 100 mg/kg body weight or ciprofloxacin(5 mg/kg body weight) for 15 days. Body temperature was measured daily during infection and treatment periods. At the end of treatment period, the animals were sacrificed and biological responses including hematological parameters, superoxide dismutase and catalase activities, and glutathione, malondialdehyde and nitric oxide concentrations were evaluated.Results: The elevated body temperature induced by infection was significantly decreased in animals treated with 25, 50 or 100 mg/kg of the extract. Platelet levels decreased slightly in infected rats, while treatment with the dichloromethane fraction of D. integrifolia significantly increased platelet levels;this response was greater than that elicited by ciprofloxacin. The doses of 50 and 100 mg/kg of the dichloromethane fraction of D. integrifolia notably decreased monocyte and neutrophil values. Activity of superoxide dismutase and catalase and levels of glutathione in the tissues of treated animals were increased significantly(P < 0.01), while malondialdehyde and nitric oxide levels were significantly decreased(P < 0.01), following treatment with the dichloromethane fraction of D. integrifolia.Conclusion: The results of this study show that the dichloromethane fraction of D. integrifolia has protective effects against a series of pathological conditions initiated by oxidation and tissue damage in the course of a S. typhi infection.Gaetan Olivier Fankem Michel Archange Fokam Tagne Paul Aime Noubissi Angèle Foyet Fondjo Idrice Kamtchouing Adela Ngwewondo Henri Wambe Joseph Ngakou Mukam Rene Kamgang 2019Journal of Integrative Medicine2019,17,6:0
15High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study显示文摘Monique Terwijn Wim L.J. van Putten Angèle Kelder Vincent H.J. van der Velden Rik A. Brooimans Thomas Pabst Johan Maertens Nancy Boeckx Georgine E. de Greef Peter J.M. Valk Frank W.M.B. Preijers Peter C. Huijgens Angelika M. Dr?ger Urs Schanz Mojca Jongen 2013Journal of Clinical Oncology2013,,31:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费